Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP310951.RAkRBtPyvUnyk7RrDfC7IZYweJYuM8WVjhq2vkSj8_lUo#assertion> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion wasGeneratedBy ECO_0000203 provenance.
- assertion wasDerivedFrom BEFREE provenance.
- assertion SIO_000772 23932550 provenance.
- assertion evidence source_evidence_literature provenance.
- assertion description "[Although the use of mipomersen and lomitapide is limited to severe familial hypercholesterolemia as a replacement for LDL-apheresis, PCSK9 inhibitors are likely to be more widely prescribed in patients at high risk for CVD, especially those who are resistant to or intolerant of high-intensity statin therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.